Treatment of Osteogenesis Imperfecta: Who, Why, What?

Publisher： Karger

E-ISSN： 1663-2826|68|5|8-11

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.68, Iss.5, 2007-12, pp. : 8-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic Acid Treatment in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 5, 2011-02 ,pp. : 346-353

Karger

Access to resources Recommend Favorite

Pamidronate Treatment of Children with Moderate-to-Severe Osteogenesis Imperfecta: A Note of Caution

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2008-11 ,pp. : 38-44

Karger

Access to resources Recommend Favorite

Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 5, 2011-02 ,pp. : 354-361

Karger

Access to resources Recommend Favorite

Reshaping of Vertebrae during Treatment with Neridronate or Pamidronate in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 5, 2011-09 ,pp. : 321-327

Karger

Access to resources Recommend Favorite

Fracture during Intravenous Bisphosphonate Treatment in a Child with Osteogenesis Imperfecta: An Argument for a More Frequent, Low-Dose Treatment Regimen

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 3, 2013-12 ,pp. : 204-210

Karger

Access to resources Recommend Favorite